Medtronic plc: Medtronic reports first quarter fiscal 2023 f

Revenue exceeds guidance, with known supply chain challenges impacting results; notable strength in Pacing, Cardiac Surgery, Core Spine in the U.S., and Diabetes in Europe DUBLIN , Aug. 23, 2022

Related Keywords

China , Dublin , Ireland , Australia , Japan , United States , New Zealand , Canada , America , Erika Winkels , Prnewswire Medtronic , Ryan Weispfenning , Geoff Martha , Karen Parkhill , Company Renal Care Solutions , Davita Inc , Linkedin , Defibrillation Solutions , Pelvic Health , Exchange Commission , Peripheral Vascular Health , Ablation Solutions , European Union , Renal Care Solutions , Medtronic , Our Mission , Cardiac Surgery , Core Spine , Specialty Therapies , Cardiovascular Portfolio , Cardiac Rhythm , Heart Failure , Structural Heart , Peripheral Vascular , Rhythm Management , Cardiac Pacing Therapies , Leadless Pacemakers , Cardiac Ablation Solutions , Western Europe , Renal Denervation , Vascular Health , Medical Surgical Portfolio , Surgical Innovations , Medical Surgical , Advanced Surgical Instruments , Wound Management , Perioperative Complications , Care Solutions , Neuroscience Portfolio , Spinal Technologies , Pain Stim , Targeted Drug Delivery , Newsroom Twitter , Investor Events , Emerging Markets , Middle East , Latin America , Eastern Europe , Mechanical Circulatory Support Operating Unit , Cash Flow , Private Securities Litigation Reform Act , Annual Report , Reports , First , Quarter , Iscal , 023 , Financial , Results ,